← 產業報告目錄
Erdosteine Market Size, Share & Trends Analysis Report By End User (Pharmaceuticals, Research Institutes, Contract Manufacturing Organisations), Application (Bronchitis, Chronic Obstructive Pulmonary Disease, Nasopharyngitis), Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-18頁數 179報告編號 INSIGHTACE-3c998576d0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 147.21 Mn as of 2022, the global Erdosteine Market is poised to climb to USD 301.61 Mn by 2031, reflecting a compound annual growth rate of 8.45% over the 2023–2031 period.
Erdosteine covers The changing environment, including increased air pollution and cigarette or tobacco smoking, has resulted in an increase in respiratory disorders and ailments. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is propelled by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Erdosteine Market Snapshot
Chapter 4. Global Erdosteine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By End-User Estimates & Trend Analysis
5.1. By End-User, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End-User:
5.2.1. Pharmaceuticals
5.2.2. Research Institutes
5.2.3. Contract Manufacturing Organizations
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:
6.2.1. Bronchitis
6.2.2. Chronic Obstructive Pulmonary Disease
6.2.3. Nasopharyngitis
6.2.4. Others
Chapter 7. Erdosteine Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Erdosteine Market revenue (US$ Million) estimates and forecasts By End-User, 2019-2031
7.1.2. North America Erdosteine Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
7.1.3. North America Erdosteine Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Erdosteine Market revenue (US$ Million) By End-User, 2019-2031
7.2.2. Europe Erdosteine Market revenue (US$ Million) By Application, 2019-2031
7.2.3. Europe Erdosteine Market revenue (US$ Million) by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Erdosteine Market revenue (US$ Million) By End-User, 2019-2031
7.3.2. Asia Pacific Erdosteine Market revenue (US$ Million) By Application, 2019-2031
7.3.3. Asia Pacific Erdosteine Market revenue (US$ Million) by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Erdosteine Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031
7.4.2. Latin America Erdosteine Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
7.4.3. Latin America Erdosteine Market revenue (US$ Million) by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Erdosteine Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031
7.5.2. Middle East & Africa Erdosteine Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
7.5.3. Middle East & Africa Erdosteine Market revenue (US$ Million) by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Alitair Pharmaceuticals
8.2.2. Berchemia Healthcare
8.2.3. Delta Finochem Pvt. Ltd.
8.2.4. Edmond Pharmaceuticals
8.2.5. Hanmi Pharmaceuticals Co. Ltd.
8.2.6. Hikma Pharmaceuticals
8.2.7. Recipharm AB
8.2.8. Shandong Luoxin Pharmaceuticals
8.2.9. Shanghai Pukang Pharmaceutical
8.2.10. Zhejiang Pharmaceutical Co. Ltd.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們